IRVINE, Calif., May 1 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry-and-Measure-Through-Motion- and-Low-Perfusion pulse oximetry, today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Health Care Conference at the InterContinental Boston in Boston, MA on Tuesday, May 6, 2008 at 9:30 a.m. ET. Joe E. Kiani, Chairman will be presenting.
A live Web cast of the presentation will be available on the Masimo Web site at http://www.masimo.com. A replay of the Web cast will be available following the live presentation.
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care -- helping solve "unsolvable" problems.
In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse
oximetry, known as Masimo SET, and with it virtually eliminated false
alarms and increased pulse oximetry's ability to detect life-threatening
events. More than 100 independent and objective studies demonstrate Masimo
SET provides the most trustworthy SpO2 and pulse rate measurements even
under the most difficult clinical conditions, including patient motion and
low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a
breakthrough noninvasive blood constituent monitoring platform that can
measure many blood constituents that previously required invasive
procedures. Rainbow SET continuously and noninvasively measures tota
|SOURCE Masimo Corporation|
Copyright©2008 PR Newswire.
All rights reserved